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Summary
Objectives: Reactive oxygen species (ROS) are now recognized to play an important role in the pathogenesis of rheumatic diseases and
constitute an interesting therapeutic target for drugs. This in vitro study was designed to evaluate the antioxidant properties of nimesulide
(NIM), a nonsteroidal antiinflammatory drug of the sulfonanilide class, and its main metabolite 4-OH nimesulide (4-OHNIM).
Methods: The scavenging effects of NIM and 4-OH NIM on hydroxyl radical (·OH) and superoxide anions (O12 ) were investigated by electron
spin resonance (ESR), using 5,5-dimethylpyrroline-N-oxide (DMPO) as the spin trap agent. The quenching properties of these drugs on
hypochlorite anion was studied by luminol enhanced chemiluminescence. Finally, the effects of NIM and 4-OHNIM on the reactive oxygen
species production by human articular chondrocytes were recorded by HRP and luminol-enhanced chemiluminescence.
Results: By this method it has been demonstrated that NIM and 4-OHNIM, at concentrations ranging from 10 to 100 M, are potent
scavengers of ·OH whereas only 4-OHNIM was capable to scavenge O12 . Chemiluminescence generated by HOCl was also significantly and
dose-dependently inhibited by both NIM and 4-OHNIM. Nevertheless, at each concentration tested, the inhibitory effect of 4-OHNIM was
significantly more marked, even at the highest concentration (100 M). Furthermore, when chondrocytes were pre-incubated for 48–96 h
with NIM or 4-OHNIM, the luminol- and HRP-dependent CL produced by the cells was significantly inhibited in a dose-dependent manner.
Conclusions: NIM and 4-OHNIM may protect cartilage against oxidative stress, not only by scavenging ROS but also by inhibiting their
production by chondrocytes. © 2000 OsteoArthritis Research Society International
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Nimesulide (NIM) is a non-steroidal antiinflammatory drug
(NSAID) commonly used in the treatment of osteoarthritis
(OA).1,2 The compound is weakly acidic (pka=6.5) and
differs from other NSAIDs in that its chemical structure
contains a sulfonanilide moiety as the acidic group.3
In humans, the drug is mostly biotransformed into
4-hydroxynimesulide (4-OHNIM), a metabolite which
appears to contribute to the antiinflammatory activity of the
compound.4 NIM appears to exert its antiinflammatory
activity through a variety of mechanisms, including a rela-
tively selective inhibition of prostaglandin synthesis by
COX-2,5–11 the inhibition of histamine release from human
basophils and tissue mast cells,12 the reduction of neu-
trophil aggregation13 and adherence to endothelial cells, as
well as the inhibition of PAF (platelet activating factor)
production by stimulated human neutrophils.14 Moreover,
NIM reduces the generation of superoxide anion by stimu-
lated polymorphonuclear leukocytes through the inhibition
of protein kinase C translocation and phosphodiesterase
type IV activity, the principal enzyme responsible for the
degradation of leucocyte cAMP.15 In a study assessing the419antioxidant activity of NIM and its main metabolites, it was
reported that 4-OHNIM possessed antilipoperoxidant
activity at a much lower concentration than the
parent compound and another metabolite recently
identified in human urine, 2-(4′-hydroxyphenoxy)-4-N-
acetylaminomethansulfonanilide.16 Using an in vitro model
of erythrocyte membrane lipoperoxidation induced by
cumene hydroperoxide (CuOOH), it was demonstrated that
4-OHNIM protects erythrocyte membrane by directly
quenching peroxyl and alkoxyl radical species.17 NIM is
also a potent scavenger of hypochlorous acid which is
responsible for large part of tissue injury and inflammation
mediated by PMNs.18 Nimesulide also exhibited favorable
hydroxyl radical scavenging activity in a membrane phos-
phatidylcholine liposome.19 Recently, NIM was reported to
induce the intracellular phosphorylation and activation of
glucocorticoid receptors and to activate their binding to
target genes in human synovial fibroblasts.20 This mechan-
ism may contribute largely to its antiinflammatory activity.
In addition to its antiinflammatory action, nimesulide may
also exert beneficial effects on osteoarthritic cartilage
metabolism. When added to human articular cartilage
explant in vitro, NIM at a therapeutic concentration (10 M),
reduced the degradation of the matrix by inhibiting the
synthesis of metalloproteinases such as collagenase and
stromelysin.21 Using primary human chondrocytes cultured
in suspension, we showed that therapeutic concentrationsAddress correspondence to: Dr Y. Henrotin, Bone and Cartilage
Research Unit, Institute of Pathology, Level +5, CHU, Sart Tilman,
4000 Lie`ge, Belgium. Tel: 32 4 366 24 67; Fax: 32 4 366 47 34;
E-mail: yhenrotin@ulg.ac.be
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HUMAN CHONDROCYTES IN CULTURE
Cartilage was obtained from the knees of eight adult
donors shortly after death (three males and five females
with a mean age of 58 years), being excised from the
superficial and medium layers and avoiding the calcified
layer. Chondrocytes were cultured for a short period in
order to maintain their phenotype. Cartilage was cut into
small fragments and then subjected to enzymatic digestion
sequentially with hyaluronidase, pronase and collagenase.
First, the fragments were incubated for 30 min at 37°C
under constant agitation (200 rpm) with hyaluronidase
(Sigma Chemie, Bornem, Belgium) dissolved (0.5 mg/ml)
in Dulbecco’s modified Eagle’s medium (DMEM, Bio-
whittaker, Bruxelles, Belgium) (10 ml enzyme solution per
3 g of cartilage). The fragments were then incubated for 1 h
at 37°C in pronase solution (1 mg/ml of DMEM; enzyme
obtained from Merck-Belgolabo, Overijse, Belgium) (3 g
cartilage per 10 ml enzyme solution). Finally, the cartilage
fragments were incubated for 20 h at 37°C under constant
agitation (200 rpm) with collagenase (Sigma Chemie) dis-
solved in DMEM (1 mg/ml) containing 1% of Ultroser G
(Gibco, Gent, Belgium) (3 g cartilage per 10 ml enzyme
solution). Ultroser G is a serum substitute designed to
replace fetal calf serum in nutrient culture medium. The
cells were then filtered through nylon mesh with a porediameter of 70 m, washed three times, counted (5×106
cells/ml) and resuspended in 10 ml of DMEM sup-
plemented with 1% of ITS+. ITS+ is a well defined culture
supplement containing 0.625 mg/ml insulin, 0.625 mg/ml
transferrin, 0.625 µg/ml selenium acid, 125 mg/ml bovine
serum albumin (BSA) and 0.535 mg/ml linoleic acid. Cells
were then kept at 37°C for 48 h under constant agitation.
After this washout period, cells (0.5×106 cells/ml) were
then seeded in 24-well plates, treated for low cell attach-
ment and cultured for 24, 48, 72 or 96 h in DMEM without
red phenol containing 1% ITS+, 1 mM glutamine and the
drugs tested. NIM and 4-OHNIM (Therabel Research,
Bruxelles, Belgium) were added to the culture medium at
concentrations ranging from 0.3 to 30 g/ml. The peak
concentrations of nimesulide reported in the plasma of RA
patients who were taking 100 mg orally twice a day ranged
from 10 to 20 M. After a single or repeated 100 mg doses
b.i.d., 10 M was above the highest level noted in the
synovial fluid of patients receiving 100 mg b.i.d. orally for
7 days, 3 h after the last dose.37 On the other hand, the
mean plasma concentration of 4-OHNIM after single-dose
administration of NIM 100 mg tablets to 12 healthy male
volunteers was 1.4 mg/l.38 NIM and 4-OHNIM were dis-
solved in 0.1 M NaOH (10 mg/ml) and diluted in DMEM
(without red phenol) at the concentration of 10 g/ml. pH
was adjusted slowly back to 7.4 with 0.1 M HCl. After
incubation, the chondrocytes suspension was collected by
centrifugation and washed three times with HBSS (pH 7.4).
The chondrocyte pellets were resuspended in 4.0 ml of
HBSS (pH 7.4) and mixed gently (cells density ±5×104/
500 l). A 500 l chondrocyte suspension was added to a
polypropylene cuvette for CL measurement.ELECTRON SPIN RESONANCE (ESR) EXPERIMENTS
The potential scavenging effect of NIM and 4-OHNIM on
O12 and ·OH was investigated by direct addition of NIM and
4-OHNIM to the O12 or ·OH generating systems. Hydroxyl
radicals (OH·) were generated by the Fenton reagents
resulting from the mixture of the following agents: 0.1 mM
H2O2, 0.01 mM FeSO4.7H2O and 10 M EDTA (Merck-
Belgolabo, Overijse, Belgium). On the other hand, super-
oxide anion was produced from xanthine (1 mM)-xanthine-
oxidase (0.08 U/ml) reaction in 50 mM phosphate buffer
(pH 7.8). The scavenging effect of NIM and 4 OHNIM on
·OH and O12 was monitored by EPR trapping technique,
using 5,5-dimethylpyrroline-N-oxide (DMPO; 100 mM;
Sigma-Aldrich, Bornem, Belgium) as the spin trap agent.
After preparation, the mixture was immediately transferred
to a flat cell and placed in the TM 110 cavity of the ESR
spectrometer (final volume 1 ml). The spectra were
recorded at room temperature using a Bruker ESP 300 E
spectrometer (Karlsruhe, Germany) operating at X-band
with 100 kHz modulation frequency. These measurements
were performed with non-saturating 20 mW microwave
power and microwave frequency 9.75 GHz. The instrumen-
tal settings were: center field 3480 G, time constant
40.96 ms, time conversion 40.96 ms, receiver gain 2×104
and sweep width 100 G.CHEMILUMINESCENCE (CL) MEASUREMENT
The in vitro effects of NIM and 4-OHNIM on the light
emission induced by sodium hypochlorite solution (NaOCl;
10−4 M; BDH Laboratory, London, U.K.) were investigated.of NIM could inhibit the synthesis of IL-6, while it did not
modify proteoglycan or IL-8 production.22 With human
osteoarthritic synovial fibroblasts in culture, NIM also
reduced the synthesis of urokinase and increased plas-
minogen activator inhibitor-1 (PAI-1), suggesting that this
drug decreases the degradation of cartilage matrix not only
by reducing metalloproteases synthesis but also by inhibit-
ing one of the mechanisms involved in metalloprotease
activation.23
The antioxidant properties of NIM suggest that this drug
could also protect cartilage by inhibiting reactive oxygen
species (ROS) production by chondrocytes. Recently, it
was reported that chondrocytes possess an NADPH
oxidase complex24,25 and produce ROS in response to
phorbol 12-myristate 13-acetate (PMA), calcium ionophore
ionomycin, anoxia-reoxygenation cycles and cytokines
(TNF, IL-1, IFN).26–29 ROS are able to degrade
matrix components (e.g. type II collagen, proteoglycans,
hyaluronic acid) and DNA by direct action30–32 and by
indirect activation of latent collagenase.33 Furthermore,
1-proteinase inhibitor, the major inhibitor of elastase, is
inactivated by exposure to the PMNs-derived oxygen
radicals species,34 awakening defences against the degra-
dative actions of proteases on connective tissues. Expo-
sure of the chondrocytes to oxygen radicals inhibits protein
and DNA synthesis in these cells,35 and depletes intra-
cellular ATP as a result of a simultaneous inactivation
of glyceraldehyde-3-phosphate dehydrogenase.36 These
findings suggest that ROS produced by chondrocytes could
play a key role in cartilage degradation and, therefore,
constitute a potential target for drugs, such as NSAIDs, that
are used in the treatment of joint diseases and possess
antioxidant side-effects.
In this work, we have investigated the capacities of NIM
and 4-OHNIM to scavenge hypochlorous anion, hydroxyl
radicals and superoxide anion and to modulate the
production of ROS by human articular chondrocytes.
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(pH 7.4). Light emission was produced by the direct reac-
tion of NaOCl (10−4 M) with luminol (2.5×10−5 M;
5-amino-2, 3-dihydro-1, 4-phthalazinedione). Chemilumi-
nescence generated by chondrocytes was also recorded
according the following protocol: luminol (5 M), chondro-
cyte suspension (5.104 cells/0.5 ml) and horseradish per-
oxidase (HRP, 0.05 U/0.5 ml) were sequentially added to a
circular polystyrene reaction vessel. To verify that light
emission was the consequence of reactive oxygen species
production, superoxide dismutase (SOD; 0.01–100 U/
0.5 ml) and catalase (0–500 U/0.5 ml) were added to the
reaction mixture. CL followed at 37°C for 10 min. CL was
measured with a BioOrbit 1251 Luminometer (Turku-
Finland) and the data were expressed in arbitrary units
(1U=1 mV).STATISTICAL ANALYSIS
The mean±S.D. for each variable was calculated.
Comparison of the treated groups with the controls was
performed using the unpaired Student’s t-test, with a
significant limit set at P<0.05.ResultsSCAVENGING EFFECTS OF NIM AND 4-OHNIM ON HO AND O12
RADICALS
The reaction of DMPO with ·OH generated by the Fenton
reaction (FeSO and H O ) resulted in a four-line ESR4 2 2spectrum (DMPO-·OH adduct). This ESR signal decreased
in the presence of increasing concentrations (10–200 M)
of NIM (IC50=5.2 M) and 4-OHNIM (IC50=4.9 M) (Fig.
1). In contrast, no inhibiting effect was observed on the O12
produced by the xanthine/xanthine oxidase system in the
presence of NIM (Fig. 2) while, at similar doses, its metabo-
lite (4-OHNIM) caused a decrease of the ESR spectrum
intensity (IC50=17 M) [Fig. 3(a), (b)]. At 10 M, which
corresponds at the peak plasmatic concentration after oral
administration of a therapeutic dose of NIM, ESR signal
height generated by ·OH was reduced by 70%, whereas
O12 ESR signal was unaffected. Inversely, at 10 M,
4-OHNIM decreased O12 ESR signal height by 38%.Fig. 1. ESR spectra (DMPO 100 mM) of the spin adduct of
hydroxyl radical generated by the Fenton reaction (H2O2 0.1 mM,
FeSO4.7H2O 0.01 mM, EDTA 0.01 mM). (a) Normal spectrum(hyperfine splittings for DMPO-·OH adduct: aH=aN=14.87 G); (b)
DMPO-·OH spectrum in the presence of NIM 50 M; (c) DMPO-
·OH spectrum in the presence of 100 M; (d) DMPO-·OH signals
was fully inhibited by NIM 200 M.Fig. 2. ESR spectra (DMPO 100 mM) of superoxide adduct
(DMPO-OOH) generated by xanthine (1 mM)/xanthine oxidase
(0.08 mU/ml) system in 50 mM phosphate buffer pH 7.4. (b,c)
Complete system xanthine/xanthine-oxidase generating superox-
ide radical in the presence of NIM 50 M (b) or 100 M (c). No
significant variation of the ESR signals was observed in the
presence of NIM.SCAVENGING EFFECTS OF NIM AND 4-OHNIM ON
CHEMICALLY-INDUCED CHEMILUMINESCENCE
The chemiluminescence generated by OHCl was dose-
dependently inhibited by NIM (IC50>100 M) and 4-OHNIM(IC50=17 M). Nevertheless, at each concentration tested
the inhibition was significantly higher in the presence of
4-OHNIM than NIM (0.01<P<0.001) (Fig. 4). At therapeutic
concentration (25 M), NIM slighly quenched (−16%) OHCl
whereas 4-OHNIM decreased light emission by 70%. At
100 M, the inhibition of OHCl-induced CL is almost com-
plete for 4-OHNIM (−95%) but not for NIM (only 38% of
inhibition).
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CHEMILUMINESCENCE
To verify that the chemiluminescence resulted from the
production of ROS by chondrocytes, we introduced two
antioxidant enzymes, superoxide dismutase (SOD) and
catalase, into the reaction mixture (Fig. 5). Interestingly,
CL generated by chondrocytes was dose-dependently
depressed by both, catalase (R=0.96; P=0.01;
y= −23.02x+51.8) and superoxide dismutase (R=0.91;
P=0.0125; y= −12.8x+22.6).
With the aim of evaluating the effects of NIM and its
metabolite, 4-OHNIM, on the ROS generating systems of
living cells, chondrocytes were pre-incubated for 24–96 h
with increased amounts of NIM and 4-OHNIM. At concen-
trations ranging from 0.4 to 10 g/ml, NIM inhibited in a
time- and dose-dependent manner CL generated by
chondrocytes (Fig. 6). In the therapeutic range of concen-
trations (6–12 M), the inhibition was already superior at
50%. After 48 h of incubation, 4-OHNIM also decreased
chemiluminescence but to a lesser extent than NIM (Fig.
7). At plasmatic concentrations of 4-OHNIM the inhibition
of the HRP- and luminol-enhanced chemiluminescence
produced by chondrocytes was less than 50% even after
96 h of incubation.Fig. 3. Effects of NIM (black columns) and 4-OHNIM (white
column) on ESR signal heights (DMPO 100 mM) generated by
hydroxyl radicals resulting from the Fenton reaction (a) and
by superoxide radical produced by xanthine/xanthine-oxidase-
system (b).Fig. 4. Effects of increase concentrations of NIM (black column)
and 4-OHNIM (white column) on the peak value of luminol
(10−4 M)-enhanced chemiluminescence curve generated by OHCl
(NaOCl). Results are expressed as the mean values of triplicate.
Statistically significant difference compared with the controls:
*P<0.05; **P<0.01; ***P<0.001.Discussion
Reactive oxygen species have been shown to play a
significant role in the degradation of cartilage in arthritis.
Recent studies suggested that rabbit, bovine, or porcine
chondrocytes are potent sources of oxygen free rad-
icals.25,27,29 Previous work from our laboratory showed that
isolated human chondrocytes were also capable of produc-
ing reactive oxygen species, such as hydrogen peroxide
and hydroxyl radicals, when they were submitted to
anoxia-reoxygenation cycle or PMA stimulation.28
As demonstrated by ESR method, NIM is a potent
scavenger of hydroxyl radical, but is ineffective on super-
oxide anions. In contrast, 4-OHNIM quenched both ·OH
and O12 . This finding can be explained by the presence of a
phenolic structure in 4-OHNIM which is particularly suscep-
tible to further O12 attack. In a previous study, Maffei-Facino
et al. demonstrated that NIM and its metabolites could
prevent ·OH-induced depolymerization of hyaluronic acid
and that the phenolic metabolite displayed maximun scav-
enging activity in the peroxidation model, where the proxi-
mate reactive damaging species were oxygen- (RO· and
ROO·) and carbon-centered (R·) lipid radicals.16 Further-
more, since we know that NIM and 4-OHNIM can bind
Fe2+, the mechanism of the action of NIM on the Fenton
reaction could be the chelation of Fe2+.16,17 This chelating
property of NIM and 4-OHNIM may also contribute to its
therapeutic potency by reducing ‘free’ iron at the inflamma-
tory site when inflammatory stimuli induce respiratory
bursts of invading leukocytes.39,40,41
Neutrophils, recruited to tissue sites of inflammation,
release a variety of oxidants and enzymes, that are respon-
sible for tissue damage. Among the oxidants released are
potent chlorinated compounds, such as hypochlorous acid,
which induce tissue cell damage and inactivate protease
inhibitors, particularly 1-antiprotease, the specific inhibitor
of neutrophil elastase. In our study, NIM and 4-OHNIM
quenched hypochlorous acid in a dose-dependent manner,
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dismutase (b) on HRP- and luminol-enhanced chemilumines-
cence. Luminol was used at the concentration of 5 M and the
reaction was started by the injection of 0.05 U of HRP.Fig. 6. Effects of increasing concentrations of NIM on HRP- and
luminol-enhanced chemiluminescence generated by human
chondrocytes. Chondrocytes were pre-incubated for 24 (——),
48 (—.—) or 72 (——) h with nimesulide. Results are means
of five experiments conducted with chondrocytes isolated from
cartilage of five different donors expressed as the percentage of
the control values. Statistically significant difference compared with
the controls: *P<0.05; **P<0.01; ***P<0.001.Fig. 7. Effects of increase concentrations of 4-OHNIM on HRP-
and luminol-enhanced chemiluminescence generated by human
chondrocytes. Chondrocytes were pre-incubated for 48 h (black
columns) or 96 h (white columns) with nimesulide metabolite.
Results are means of three experiments conducted with chondro-
cytes isolated from cartilage of three different donors. For each
individual experiment, four culture flasks were used for each
concentration of 4-OHNIM as well as for the corresponding con-
trols. Results are expressed as the percentage of the control
values. Statistically significant difference compared with the
controls: *P<0.05; **P<0.01; ***P<0.001.as demonstrated by the luminol-enhanced chemilumines-
cence method. Nevertheless, at each concentration tested
the inhibition was significantly more marked in the pres-
ence of 4-OHNIM than in that of NIM. Other studies have
also shown that NIM, at therapeutic concentrations (10–
100 mol/l), prevented the inactivation of 1-antiprotease
by neutrophils by effectively scavenging the hypochlorous
acid released by neutrophils.42 In contrast, aspirin and
naproxen were completely ineffective, suggesting that the
presence of an NH group, particularly exposed at the
surface of the NIM and therefore prone to chlorination by
OHCl, probably accounts for the observed effect of NIM.42
On the other hand, our results also demonstrate that
4-OHNIM is a stronger OHCl scavenger than NIM, suggest-
ing that the OH group could also react with OHCl. At
10 mol/l (equal to 3.08 mg/l) which corresponds to the
level of NIM found in plasma after a single 100 mg oral
dose, NIM and 4-OHNIM inhibited OHCl-induced chemilu-
minescence by 11% and 38% respectively, suggesting that
in vivo, 4-OHNIM could be the active compound in this
process.
The production of ROS by isolated chondrocytes can be
estimated by measurement of the chemiluminescence.27,29
Due to the low quantum yield of ROS, it is difficultto measure the intrinsic CL produced by chondrocytes.
Luminescence enhancers such as luminol (5-amino-
2,3-dihydro-1,4-phthalazine-dione) and lucigenin are
susceptible to oxygenations and of high CL yield. Luminol-
dependent or lucigenin-dependent CL in articular
chondrocytes has been established by Rathakrishnan
et al.27,29 Luminol-dependent CL is considered to reflect
the production of hydrogen peroxide, peroxynitrite, super-
oxide and singlet oxygen.43–47 In this study, we have
developed an HRP- and luminol-dependent CL assay to
measure the production of ROS by cultured human
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Drugs 1993;46(Suppl 1):34–9.chondrocytes. Both luminol and HRP are necessary to the
CL measurement. In the absence of these chemilumi-
nescence enhancers, chondrocytes failed to emit chemilu-
minescence. Both catalase and superoxide dismutase fully
suppressed chemiluminescence generated by chondro-
cytes, indicating that this assay measures the production of
hydrogen peroxide and superoxide anions by chondro-
cytes. When chondrocytes were pre-incubated with NIM
and 4-OHNIM, HRP- and luminol-dependent chemilumi-
nescence was dose- and time-dependently decreased.
These findings suggest that NIM not only acts as a scav-
enger of ROS, but also inhibits the intracellular generating
system of ROS. At the present time, two mechanisms have
been advanced to explain the inhibitory effect of NIM on
ROS production by leukocytes. By analogy, we can specu-
late that the effect of NIM on oxygen free radicals (super-
oxide anion, O12 ) may be related to its inhibitory activity on
cytosolic phosphodiesterase type IV (cAMP-specific), thus
increasing cytosolic cAMP and, as a consequence, protein
kinase A activity, which promotes the phosphorylation of a
number of intracellular factors and inhibits the assembly of
NADPH-oxidase in the plasma membrane.15 Another
mechanism of the action of NIM could be direct interference
with the adenosine receptor system on the cell membrane.
Recently, it was demonstrated that the pre-incubation of
cells with the specific adenosine receptor antagonist theo-
phylline was able to significantly reverse the inhibitory
activity of NIM on free radicals production sustained by
FMLP and the ionophores,45 suggesting the possibility that
NIM interferes directly with the adenosine receptor system
on the cell membrane.
In conclusion, our study demonstrates for the first time
that an NSAID may inhibit ROS production by human
chondrocytes. By this way, nimesulide could locally protect
cartilage against the deleterious effects of ROS on the
cartilage matrix integrity. This study also shows that the
parent drug nimesulide, and its metabolite, may have
different scavenging effects, suggesting that drug metabo-
lization could also influence the drug efficacy. Finally, we
must keep in mind that the reaction of NSAIDs with ROS
could also conduct to the formation of transient radical
species which could act as electron donors and initiate
oxidative chain reaction.48 The presence of excited state of
the NSAID should be researched before a definitive con-
clusion is reached on their antioxidant properties.
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